Viscient to bioprint lung tissues to accelerate COVID-19 research
April 1, 2020 -- Biotherapeutics company Viscient Biosciences said it, or a sister company to be funded and launched shortly using the same technology, will use 3D bioprinting technology to create lung tissue to support viral infectivity research and search for an effective therapy against SARS-CoV-2, the novel coronavirus which causes COVID-19. Read More
Kleo, Green Cross collaborate on COVID-19 NK combination therapy
March 31, 2020 -- Kleo Pharmaceuticals is joining forces with Green Cross LabCell of South Korea to advance testing of natural killer (NK) cell therapies as a potential treatment for COVID-19 patients. Read More
Generation Bio, Vir partner for mAbs against COVID-9
March 30, 2020 -- Generation Bio and Vir Biotechnology have agreed to collaborate on research into the use of monoclonal antibodies against the SARS-CoV-2 virus that causes COVID-19. Read More
J&J seeks to release COVID-19 vaccine by 2021
March 30, 2020 -- Johnson & Johnson has selected a lead COVID-19 vaccine candidate from a number of options it has been working on since January. The company hopes to release a vaccine by 2021. Read More
LabShares Newton offers free space for COVID-19 research
March 30, 2020 -- LabShares Newton is offering free, fully equipped biosafety level 2 lab space, facilities, and resources for researchers addressing the global COVID-19 pandemic, it announced on March 30. Read More
Simulations Plus debuts COVID-19 consulting program
March 27, 2020 -- Medical simulation software company Simulations Plus announced that it has created a program to speed up consulting assistance to scientists working on COVID-19 research. Read More
Atum gives labs free access to protein production platform
March 27, 2020 -- Atum has granted commercial and academic laboratories free access to its Leap-In Transposase protein production platform for use in creating tools and resources to battle the COVID-19 pandemic. Read More
Xencor, Vir partner on COVID-19 antibodies research
March 27, 2020 -- Biopharmaceutical companies Xencor and Vir Biotechnology have entered into a technology licensing agreement to develop potential antibody-based treatments for patients with COVID-19. Read More
Vycellix, Avectas partner for product development
March 26, 2020 -- Vycellix and Avectas have unveiled plans to collaborate on the development of cell-based immunotherapeutic products. Read More
COVID-19 causes long-term disruptions to clinical trials
March 26, 2020 -- New survey results suggest that clinical trials are experiencing significant roadblocks associated with COVID-19. These could ultimately result in a slowdown of global drug development, according to Clinical Research IO. Read More
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter